Michael Calore Joins 5AM Ventures as Partner, Head of Investor Relations SAN FRANCISCO and BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- 5AM Ventures is pleased to announce the addition of Michael Calore as Partner, Head of Investor Relations. “We are excited to have...

5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science SAN FRANCISCO and BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- 5AM Ventures is pleased that the U.S. Food and Drug Administration (FDA) approved REZZAYO™ (rezafungin for injection) for the treatment...

Anna Yaeger Joins 5AM Ventures as Partner, Head of Public Equities SAN FRANCISCO and BOSTON, Oct. 19, 2022 (GLOBE NEWSWIRE) -- 5AM Ventures is pleased to announce the addition of Anna Yaeger as Partner, Head of Public Equities. 5AM has raised over $2.2 billion...

Arthur Tzianabos, Ph.D., June Lee, MD FACCP, and Joseph Loscalzo, MD, Ph.D. Join 5AM Ventures SAN FRANCISCO and BOSTON, Sept. 27, 2022 (GLOBE NEWSWIRE) -- 5AM Ventures, a bicoastal venture capital firm, continues to attract preeminent talent as it celebrates 20 years of investing in...

5AM Ventures Closes $750 Million Across Two Life Science Funds and Announces Team Additions SAN FRANCISCO and BOSTON, April 04, 2022 (GLOBE NEWSWIRE) -- 5AM Venture Management, LLC (“5AM”) is pleased to announce the closing of two new funds, totaling $750 million in committed capital. 5AM...